Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose vs Regular-Dose Nicotine Patch in Schizophrenia
NCT00046813Phase 4Terminated
- Sponsor
- National Institute on Drug Abuse
- Start
- Aug 2001
- Primary completion
- Apr 2005
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Continuous abstinence from smoking at 8 weeks. Started Aug 2001; status: terminated.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00046813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046813.